Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
XIAO-I ADR | AIXI | 26. dec 2024 | 6.24 | +18.91 |
Xilio Therapeutics | XLO | 26. dec 2024 | 0.97 | -15.22 |
Xinyuan Real Estate ADR | XIN | 26. dec 2024 | 2.56 | +6.22 |
XOMA | XOMA | 26. dec 2024 | 27.28 | +0.55 |
XOMA A Pref | XOMAP | 26. dec 2024 | 25.87 | -0.12 |
XOMA B Pref | XOMAO | 26. dec 2024 | 25.71 | +0.43 |
Xometry A | XMTR | 26. dec 2024 | 44.66 | +2.20 |
XORTX Therapeutics | XRTX | 26. dec 2024 | 1.12 | +0.54 |
Xos | XOS | 26. dec 2024 | 3.27 | -1.51 |
XP A | XP | 26. dec 2024 | 12.18 | +0.50 |
XPEL | XPEL | 26. dec 2024 | 40.20 | -0.94 |
XPeng A ADR | XPEV | 26. dec 2024 | 13.26 | +2.16 |
Xperi | XPER | 26. dec 2024 | 10.35 | +0.58 |
XPO Logistics | XPO | 26. dec 2024 | 133.17 | -1.38 |
Xponential Fitness A | XPOF | 26. dec 2024 | 12.96 | -0.84 |
Xtant Medical | XTNT | 26. dec 2024 | 0.43 | +9.81 |
XTL Biopharmaceuticals ADR | XTLB | 26. dec 2024 | 2.10 | +11.70 |
Xunlei ADR | XNET | 26. dec 2024 | 2.10 | +4.74 |
XWELL | XWEL | 26. dec 2024 | 1.60 | +1.91 |
Xylem | XYL | 26. dec 2024 | 118.47 | +0.27 |
Xylo Technologies ADR | XYLO | 26. dec 2024 | 3.67 | +0.69 |
Y-mAbs Therapeutics | YMAB | 26. dec 2024 | 8.00 | -1.84 |
Yalla ADR | YALA | 26. dec 2024 | 4.20 | +1.20 |
Yatra Online | YTRA | 26. dec 2024 | 1.30 | +1.95 |
Yatsen ADR | YSG | 26. dec 2024 | 4.77 | +1.71 |
Yelp | YELP | 26. dec 2024 | 39.70 | +1.87 |
YETI | YETI | 26. dec 2024 | 39.38 | +0.18 |
Yext | YEXT | 26. dec 2024 | 6.45 | +0.78 |
YHN Acquisition I | YHNA | 26. dec 2024 | 10.04 | 0.00 |
YHN Acquisition I Limited - Unit | YHNAU | 26. dec 2024 | 10.10 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.